Lv31
350 积分 2022-09-25 加入
Therapeutic siRNA: State-of-the-Art and Future Perspectives
7小时前
已完结
CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus
30天前
已完结
Chemically Modified Platforms for Better RNA Therapeutics
4个月前
已完结
Move over, CRISPR: RNA-editing therapies pick up steam
4个月前
已完结
The 60-year evolution of lipid nanoparticles for nucleic acid delivery
4个月前
已完结
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
4个月前
已完结
Peptide codes for organ-selective mRNA delivery
4个月前
已完结
Tissue-specific mRNA delivery and prime editing with peptide–ionizable lipid nanoparticles
4个月前
已完结
Tumour-associated vasculature in T cell homing and immunity: opportunities for cancer therapy
5个月前
已完结
The tumour microenvironment in pancreatic cancer — clinical challenges and opportunities
5个月前
已完结
皖公网安备34019202002308
